Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Heinzer

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 15